Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | glucagon-like peptide 1 receptor | Starlite/ChEMBL | No references |
Influenza A virus | Nonstructural protein 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Loa Loa (eye worm) | pigment dispersing factor receptor c | glucagon-like peptide 1 receptor | 463 aa | 388 aa | 25.8 % |
Mycobacterium tuberculosis | Hypothetical protein | Nonstructural protein 1 | 230 aa | 202 aa | 23.8 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium ulcerans | ATPase | 0.0035 | 0.3493 | 0.5 |
Brugia malayi | valosin containing protein | 0.0034 | 0.3316 | 0.2765 |
Mycobacterium tuberculosis | Putative conserved ATPase | 0.0035 | 0.3493 | 0.5 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.006 | 1 | 1 |
Giardia lamblia | AAA family ATPase | 0.0035 | 0.3493 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.006 | 1 | 1 |
Trypanosoma cruzi | Valosin-containing protein, putative | 0.0055 | 0.8665 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0041 | 0.5143 | 0.5057 |
Entamoeba histolytica | cdc48-like protein, putative | 0.0055 | 0.8665 | 0.5 |
Toxoplasma gondii | cell division protein CDC48AP | 0.0035 | 0.3493 | 0.0000097958 |
Leishmania major | Transitional endoplasmic reticulum ATPase, putative,valosin-containing protein homolog | 0.0055 | 0.8665 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0034 | 0.3316 | 0.2765 |
Loa Loa (eye worm) | vesicle-fusing ATPase | 0.0034 | 0.3316 | 0.2765 |
Echinococcus granulosus | transitional endoplasmic reticulum atpase | 0.0058 | 0.9426 | 0.5 |
Plasmodium vivax | cell division cycle protein 48 homologue, putative | 0.0055 | 0.8665 | 1 |
Echinococcus multilocularis | transitional endoplasmic reticulum atpase | 0.0058 | 0.9426 | 1 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0041 | 0.5143 | 0.4743 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0055 | 0.8665 | 0.9122 |
Plasmodium falciparum | cell division cycle protein 48 homologue, putative | 0.0055 | 0.8665 | 0.5 |
Brugia malayi | vesicle-fusing ATPase | 0.0034 | 0.3316 | 0.2765 |
Trypanosoma brucei | Valosin-containing protein | 0.0055 | 0.8665 | 0.5 |
Toxoplasma gondii | cell division protein CDC48CY | 0.0058 | 0.9426 | 1 |
Entamoeba histolytica | transitional endoplasmic reticulum ATPase, putative | 0.0055 | 0.8665 | 0.5 |
Trichomonas vaginalis | spermatogenesis associated factor, putative | 0.0058 | 0.9426 | 0.5 |
Onchocerca volvulus | Transitional endoplasmic reticulum ATPase homolog | 0.0058 | 0.9426 | 0.5 |
Schistosoma mansoni | cell division control protein 48 aaa family protein | 0.0058 | 0.9426 | 1 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.006 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.5143 | 0.4743 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 7.9433 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 15.8489 um | PUBCHEM_BIOASSAY: qHTS Assay for Inhibitors of Influenza NS1 Protein Function. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | = 35.4813 um | PUBCHEM_BIOASSAY: qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP). (Class of assay: confirmatory) [Related pubchem assays: 1482, 1471 ] | ChEMBL. | No reference |
Potency (functional) | 100 uM | PUBCHEM_BIOASSAY: HTS for Inhibitors of HP1-beta Chromodomain Interactions with Methylated Histone Tails. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488962] | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.